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1 |  INTRODUCTION
Acute hemorrhagic leukoencephalitis (AHLE) is a rare but 
an aggressive form of acute disseminated encephalomyelitis 
(ADEM).1,2 It is often associated with cerebral edema, pete-
chial hemorrhage, and necrotizing vasculitis in the brain.3,4 
These changes frequently affect cerebral white matter, pre-
dominantly in the perivascular area.1-3 Diffuse cerebral edema 
can rapidly progress to brain herniation, which has a mortality 
rate of 70%.1 The etiology is unclear, but it is thought to be 
triggered by cross‐reactivity between a viral or bacterial an-
tigen and the patient’s myelin protein, leading to autoimmune 
demyelination.1,3 The onset is sudden and the patient usually 
presents within a few days following a viral or bacterial illness 
with signs of meningoencephalitis.3 Diagnosis can be made 
with a computed tomography (CT) scan or magnetic resonance 
imaging (MRI) of the brain.2,3 A brain biopsy shows demyelin-
ation, hemorrhage, and infiltrates of macrophages, neutrophils 
and mononuclear cells in perivascular areas.1-4 Prompt diagno-
sis, vigorous intracranial pressure (ICP) control, and treatment 
with immunosuppressive therapy and plasmapheresis are as-
sociated with better outcomes and increased survival rates.1,4
2 |  CASE REPORT
An 8‐year‐old boy presented to us with a 2‐day his-
tory of fever, vomiting, and severe headache. His past 
medical history included two episodes of concussion and a 
recent upper respiratory infection. His initial examination 
was unremarkable. Given the history of head trauma, a 
head CT scan was obtained and it revealed asymmetrical 
white matter hypodensity and edema in the right frontal 
and temporal lobes without evidence of hemorrhage or 
midline shift, of concern in cases of meningoencephali-
tis. Cerebrospinal fluid (CSF) was collected and showed 
marked leukocytosis (1660 cells/L) and increased protein 
levels (250 mg/dL). The patient was started on ceftriax-
one and vancomycin. Within a few hours after admission, 
the patient’s condition deteriorated with left‐sided hemi-
paresis and altered mental status. His airway was secured 
with successful intubation. A brain MRI was obtained and 
showed patchy areas of enhancement throughout the right 
cerebral white matter, midbrain, and pons with significant 
fluid‐attenuated inversion recovery (FLAIR) changes—
highly suggestive of ADEM. There was minimal right to 
left midline shift (Figure 1A). Aggressive management of 
high ICP was initiated due to a concern for cerebral her-
niation. It included head elevation, hyperosmolar therapy, 
therapy to maintain euthermia and carbon dioxide level 
in normal physiological range, sedatives and anti‐epilep-
tic medications to limit brain hyperactivity. The neuro-
surgical team was consulted for invasive ICP monitoring 
and for a possible brain biopsy to confirm the diagnosis 
of ADEM or AHLE. The patient was started on a pulse 
dose of intravenous methylprednisolone of 30 mg/kg/d 
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for 5 days. On the second day of admission, the patient 
started posturing with further deterioration. A repeat MRI 
showed worsening of the midline shift with early tonsil-
lar herniation secondary to massive edema, now involving 
both hemispheres (Figure 1B). The MRI further showed a 
new hemorrhage in the right cerebral hemisphere. Based 
on the rapid deterioration of his clinical status and new 
findings of hemorrhage with widespread white matter cer-
ebral edema on the MRI, the diagnosis of AHLE was clini-
cally made. An external ventricular drain (EVD) was put 
in place and the patient started on plasmapheresis (volume 
1.0). Plasmapheresis was continued for 5 days without no-
table clinical improvement. Subsequently, the patient was 
given a dose of intravenous immunoglobulin (IVIG) 2 g/
kg for two days. A dramatic improvement in his menta-
tion, neurological deficits, and ICP followed over the next 
few days. The EVD and endotracheal tube were removed, 
and the patient weaned off sedative medications and hy-
perosmolar therapy. A repeat MRI on day 15 post‐admis-
sion showed marked improvement in the cerebral edema 
with a complete resolution of the midline shift and tonsil-
lar herniation (Figure 1C). He had an extensive infectious 
disease workup that was entirely negative (Table 1). On 
hospital day 20, the patient was transferred to a rehabili-
tation facility with levetiracetam and a tapering dose of 
prednisolone.
3 |  DISCUSSION
Acute hemorrhagic leukoencephalitis, also known as Hurst 
disease, after Dr E. Weston Hurst who first described it in 
1941, is a fatal form of ADEM.3 It is characterized by diffuse 
inflammation and hemorrhagic necrosis of white matter pre-
dominantly around the small parenchymal blood vessels.1,3,4 
The etiology of AHLE is unclear, but studies suggest it results 
from the autoimmune destruction of white matter that occurs 
secondary to a cross‐reactivity phenomenon following a viral 
or bacterial illness.1,3 Various viruses and bacteria (Table 1) 
have been associated with ADEM/AHLE.1,3,4 Tenembaum 
found a genetic predisposition for AHLE in patients with par-
ticular major histocompatibility complex (MHC) haplotypes.5
Patients with AHLE present abruptly (within a few days of 
illness onset) with fever, headache, meningismus, seizure, or 
focal neurological deficit.3 The differential diagnosis includes 
meningoencephalitis, ADEM, stroke, autoimmune encepha-
litis or vasculitis, multiple sclerosis, and leukodystrophies.2,3 
Diagnosis can be made clinically and, more importantly, by 
CSF studies, CT scans, MRIs, and a brain biopsy.2,3 CSF 
studies are typically positive for leukocytosis and increased 
protein levels, and negative for cultures and for polymerase 
chain reaction testing for infectious causes.2,3 A head CT scan 
may show hypodensities in affected white and gray matter.3 A 
brain MRI will show hyperintense T2‐weighted lesions. The 
FLAIR sequence will provide better visualization.2,3 A brain 
biopsy may reveal the pathognomonic findings of demyelin-
ation, hemorrhagic necrosis, and perivascular infiltrates.1,3 
While direct brain tissue examination provides a definitive 
diagnosis,3 it may not be feasible in all patients with suspected 
AHLE. The diagnosis can be made clinically based on symp-
tom severity, clinical course of the disease, and radiological 
findings.2 ADEM and AHLE share radiological findings, but 
AHLE typically has extensive cerebral edema and it frequently 
presents with intracranial hemorrhage.6
F I G U R E  1  A, MRI (on Day 1 of admission) showing patchy enhancement of cerebral white matter associated with a mild right to left 
midline shift. B, MRI (on Day 2 of admission) showing a marked progression of diffuse cerebral edema of bilateral white matter, right more than 
left, with worsening of a midline shift. C, MRI (on Day 15 of admission) showing significant improvement in cerebral edema (less hyperintense 
white matter area) with a near complete resolution of a midline shift
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Acute hemorrhagic leukoencephalitis carries a poor 
prognosis, with death typically occurring within a week 
of onset due to increased ICP.1-4 Treatment of AHLE can 
change the fulminant course of the disease.1,4 Treatment 
first includes aggressive control of ICP, which sometimes 
requires decompressive craniectomy.1 However, most pa-
tients can be managed medically. The second part of treat-
ment consists of immunomodulation therapy to address the 
ongoing intense inflammation. There are no established 
treatment guidelines for AHLE.3,4 but multiple case reports 
and small studies support the use of high‐dose steroids, 
IVIG, and plasmapheresis as the mainstay treatment for 
AHLE.2-4 Ideally, a pulse dose of IV methylprednisolone 
should be started on initial presentation along with anti-
biotics and acyclovir. It should be continued for 3‐5 days 
followed by oral prednisolone for 4‐6 weeks.5 Various case 
reports and small studies have demonstrated the effective-
ness of daily IVIG therapy either as a single dose or as a 
five‐day course.7 Although no therapeutic trials comparing 
IVIG and plasmapheresis for the management of AHLE 
exist, the evidence from numerous case reports and series 
emphasizes the use of plasmapheresis when steroid and 
IVIG fail.4,8 Due to a concern that plasmapheresis adminis-
tered immediately after IVIG would decrease effectiveness 
of IVIG, we decided to try IVIG after plasmapheresis only 
if the latter failed to improve the condition. To our surprise, 
the patient’s condition improved dramatically after two 
doses of IVIG therapy with a slow return of mental and 
neurological status over next few days. To our knowledge, 
this is the first case of plasmapheresis‐refractory pediatric 
AHLE being successfully treated with IVIG without signif-
icant morbidity.
In conclusion, AHLE should be considered in patients 
with suspected ADEM who show rapid clinical deterioration. 
Treatment should include pulse dose steroid and plasmapher-
esis. We recommend considering IVIG if plasmapheresis is 
ineffective to treat AHLE.
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Viruses Herpes simplex 
virus
Cytomegalovirus
Epstein‐Barr  
virus
Human herpesvi-
rus 6
Varicella zoster 
virus
Respiratory 
syncytial virus
Influenza
John Cunningham 
virus
West Nile
California
Eastern and 
western equine 
viruses
Bacteria Mycoplasma
Borrelia 
burgdorferi
Streptococcus
Leptospira
Chlamydia
Rickettsia
T A B L E  1  Common pathogens 
associated with AHLE
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